Lockheed Martin Receives US Approval in UTC Deal
Sikorsky Helicopters has finally found a home in Lockheed Martin, pending final approvals.
All Work
Chris Lange
SiteOne Landscape Supply Gears Up for IPO
SiteOne Landscape Supply has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Bioceres Files for IPO
Bioceres has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
How Caterpillar Plans to Deal With Slowing Markets
Caterpillar announced Thursday it plans a reorganization of its divisions across the company in an effort to improve efficiency and reduce complexity.
Why Oppenheimer Says Alexion Is a Cheap Buy Now
Oppenheimer maintained its Outperform rating for Alexion Pharmaceuticals with a price target that implies upside of more than 40%.
Arrowhead Jumps in Anticipation of Analyst Day
Arrowhead Research shares soared in early trading indications Thursday in anticipation of its analyst day.
Conatus Pharmaceuticals Soars on Positive Phase 2 Results
Conatus Pharmaceuticals has announced that its exploratory Phase 2 portal hypertension clinical trial of emricasan met its primary endpoints.
Fitch Revises Revenue Forecast for Macau and Major Casinos
ThinkstockAs a result of Macau’s gaming revenues being down 36.5% year to date through August, and the corruption crackdown in China, Fitch Ratings is revising its Macau 2015 gaming revenue growth forecast. In part the…
What to Expect From Nike Earnings
Nike is scheduled to report its fiscal first-quarter financial results after the markets close on Thursday.
What to Expect From Bed Bath & Beyond Earnings
Bed Bath & Beyond is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.
Why Key Analyst Sees 25% Upside in Intuitive Surgical
Canaccord Genuity reiterated a Buy rating on Intuitive Surgical with a price target that implies upside of 25% from current prices.
Intra-Cellular Sets Price for Secondary Offering
Intra-Cellular Therapies is gearing up for its secondary offering, and in preparation it just set the price.
Heron Therapeutics Soars on Positive Phase 2 Results
Heron Therapeutics Inc. (NASDAQ: HRTX) is bucking the trend of a biotechs and pharmas selling off in the wake of Hillary’s tweet. In fact the company was one of those leading the health care…
What Signal Genetics Gets With New Master Service Agreement
ThinkstockSignal Genetics Inc. (NASDAQ: SGNL) soared right out of the gate Wednesday morning on word of a new agreement. Basically, the company announced the signing of a master service agreement (MSA) with a leading…
Orexigen Therapeutics Receives $15 Million Milestone Payment
Orexigen Therapeutics has announced receipt of the first of three potential $15 million anniversary milestone payments from Takeda Pharmaceuticals.
GE Plans Expansion for Health Care and Tech Segment
GE has announced the creation of a new business unit, Sustainable Healthcare Solutions, which will develop high-value, low-cost technologies and health care delivery solutions across multiple care settings.
Is FedEx Now a Cheap Stock?
By Tkgd2007 at en.wikipedia , from Wikimedia CommonsFedEx Corp. (NYSE: FDX) is a leading international provider of package delivery, and one key analyst thinks that now might be a good time to buy in.…
Why 3M Is a Bargain After the Sell-Off
Courtesy 3M CompanyAs a diversified tech company with worldwide operations, 3M Co. (NYSE: MMM) stands to make some headway in the international market, at least according to one key analyst. Argus has a very…
Digicel Sets Terms for IPO in Most Recent Filing
Digicel Group expects to price approximately 124 million shares in the range of $13 to $16 for its initial public offering.
How Key Analyst Sees PBMs Responding to Hillary’s Tweet
The recent outcry on social media, focusing on drug pricing, is likely to draw attention to the role of pharmacy benefit managers.